Otsuka (OTCMKTS:OTSKY) Shares Up 1.2% – Time to Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) shot up 1.2% during mid-day trading on Monday . The company traded as high as $29.60 and last traded at $29.4710. 36,695 shares traded hands during trading, an increase of 31% from the average session volume of 27,981 shares. The stock had previously closed at $29.13.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, Otsuka presently has an average rating of “Strong Buy”.

Otsuka Price Performance

The stock has a 50 day simple moving average of $28.48 and a two-hundred day simple moving average of $26.90.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.